Zhuoyan Peptides
Retatrutide
Finnrick tested 2 samples of Retatrutide (GLP-1, GIP, and GCGR agonist) from Zhuoyan Peptides between 13 May 2026 and 18 May 2026. Test scores average below 4 or some scores below 3, and at least 2 tests, warrant a tentative Finnrick Rating of E (Bad).
Finnrick Rating™
Tentative Rating
Zhuoyan Peptides
Retatrutide
Tested 2 Samples
Last test 18 May 2026
Take Action
Free peptide testing
Mail in a sample (US only) to get confidence for the specific vials you have, and contribute to identifying unsafe supply chains, so other people can avoid risky and costly mistakes.
Other Retatrutide tests from top-rated vendors:
All Retatrutide tests from Zhuoyan Peptides
Samples are tested in commercial labs
Tests Count
2
Scores
AVGMINMAX
Last
18 May 2026
First
13 May 2026
| Quantity | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Test Date | Certificate | Test Score | Label | Tested | Difference | Purity | Batch ID | Container | Tested At | Sent By |
| 18 May 2026 | View | 10mg | ⚠️ Sample does not contain Retatrutide | 3.2.2026 | No label / Silver crimp / White cap | Lab G | Public | |||
| 13 May 2026 | View | 10mg | 10.1mg | +1.0% | 99.70% | 3/2/26 | No label / Silver crimp / Yellow cap | Lab G | Public | |